These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor. Palombella VJ; Mendelsohn J; Vilcek J J Cell Physiol; 1988 Apr; 135(1):23-31. PubMed ID: 3259236 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line. Le J; Reis LF; Vilcek J Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383 [TBL] [Abstract][Full Text] [Related]
4. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082 [TBL] [Abstract][Full Text] [Related]
5. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors. Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744 [TBL] [Abstract][Full Text] [Related]
6. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. Ahmad F; Goldstein BJ J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells. Dunne SL; Bajzer Z; Vuk-Pavlović S Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259 [TBL] [Abstract][Full Text] [Related]
8. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. Mawatari M; Kohno K; Mizoguchi H; Matsuda T; Asoh K; Van Damme J; Welgus HG; Kuwano M J Immunol; 1989 Sep; 143(5):1619-27. PubMed ID: 2547871 [TBL] [Abstract][Full Text] [Related]
9. TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. Battegay EJ; Raines EW; Colbert T; Ross R J Immunol; 1995 Jun; 154(11):6040-7. PubMed ID: 7751646 [TBL] [Abstract][Full Text] [Related]
10. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165 [TBL] [Abstract][Full Text] [Related]
11. TNF-alpha bifunctionally induces proliferation in primary hepatocytes: role of cell anchorage and spreading. Watanabe Y; Osaki H; Akaike T J Immunol; 1997 Nov; 159(10):4840-7. PubMed ID: 9366409 [TBL] [Abstract][Full Text] [Related]
12. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation. Donato NJ; Ince C; Rosenblum MG; Gallick GE J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Sugo S; Minamino N; Shoji H; Kangawa K; Kitamura K; Eto T; Matsuo H Biochem Biophys Res Commun; 1995 Feb; 207(1):25-32. PubMed ID: 7857273 [TBL] [Abstract][Full Text] [Related]
14. Retinoic acid differentially affects platelet-derived growth factor and epidermal growth factor-regulated cell growth of mouse osteoblast-like cells. Tsukamoto T; Matsui T; Takaishi T; Ito M; Fukase M; Chihara K Cell Growth Differ; 1994 Feb; 5(2):207-12. PubMed ID: 8180134 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of cytokines on vascular endothelial cells: synergistic interactions among interferon-gamma, tumor necrosis factor-alpha, and interleukin-1. Norioka K; Borden EC; Auerbach R J Immunother (1991); 1992 Jul; 12(1):13-8. PubMed ID: 1637780 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Hambek M; Solbach C; Schnuerch HG; Roller M; Stegmueller M; Sterner-Kock A; Kiefer J; Knecht R Cancer Res; 2001 Feb; 61(3):1045-9. PubMed ID: 11221831 [TBL] [Abstract][Full Text] [Related]
17. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related]
18. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma. Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567 [TBL] [Abstract][Full Text] [Related]
19. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor. Shieh JH; Peterson RH; Warren DJ; Moore MA J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961 [TBL] [Abstract][Full Text] [Related]